A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema

Barrett Katz

Research output: Contribution to journalArticlepeer-review

552 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema'. Together they form a unique fingerprint.

Medicine & Life Sciences